Literature DB >> 19650713

Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.

William I Sivitz1, Mark A Yorek.   

Abstract

Given their essential function in aerobic metabolism, mitochondria are intuitively of interest in regard to the pathophysiology of diabetes. Qualitative, quantitative, and functional perturbations in mitochondria have been identified and affect the cause and complications of diabetes. Moreover, as a consequence of fuel oxidation, mitochondria generate considerable reactive oxygen species (ROS). Evidence is accumulating that these radicals per se are important in the pathophysiology of diabetes and its complications. In this review, we first present basic concepts underlying mitochondrial physiology. We then address mitochondrial function and ROS as related to diabetes. We consider different forms of diabetes and address both insulin secretion and insulin sensitivity. We also address the role of mitochondrial uncoupling and coenzyme Q. Finally, we address the potential for targeting mitochondria in the therapy of diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19650713      PMCID: PMC2824521          DOI: 10.1089/ars.2009.2531

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  349 in total

Review 1.  Nitric oxide, mitochondria, and cell death.

Authors:  G C Brown; V Borutaite
Journal:  IUBMB Life       Date:  2001 Sep-Nov       Impact factor: 3.885

2.  Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.

Authors:  C Y Zhang; G Baffy; P Perret; S Krauss; O Peroni; D Grujic; T Hagen; A J Vidal-Puig; O Boss; Y B Kim; X X Zheng; M B Wheeler; G I Shulman; C B Chan; B B Lowell
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

Review 3.  Transcriptional coregulators in the control of energy homeostasis.

Authors:  Jérôme N Feige; Johan Auwerx
Journal:  Trends Cell Biol       Date:  2007-05-01       Impact factor: 20.808

Review 4.  Mitochondrial energetics and insulin resistance.

Authors:  Anthony E Civitarese; Eric Ravussin
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

Review 5.  PDH kinase inhibitors: a novel therapy for Type II diabetes?

Authors:  R M Mayers; B Leighton; E Kilgour
Journal:  Biochem Soc Trans       Date:  2005-04       Impact factor: 5.407

6.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

7.  The reaction of no with superoxide.

Authors:  R E Huie; S Padmaja
Journal:  Free Radic Res Commun       Date:  1993

Review 8.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

9.  Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy.

Authors:  Masao Kanauchi; Hisayuki Nishioka; Toshio Hashimoto
Journal:  Nephron       Date:  2002-06       Impact factor: 2.847

10.  Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.

Authors:  Matthias L Jauslin; Thomas Meier; Robin A J Smith; Michael P Murphy
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

View more
  242 in total

1.  Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance.

Authors:  Laura Formentini; Alexander J Ryan; Manuel Gálvez-Santisteban; Leslie Carter; Pam Taub; John D Lapek; David J Gonzalez; Francisco Villarreal; Theodore P Ciaraldi; José M Cuezva; Robert R Henry
Journal:  Diabetologia       Date:  2017-08-02       Impact factor: 10.122

2.  Aldehyde oxidase functions as a superoxide generating NADH oxidase: an important redox regulated pathway of cellular oxygen radical formation.

Authors:  Tapan K Kundu; Murugesan Velayutham; Jay L Zweier
Journal:  Biochemistry       Date:  2012-03-19       Impact factor: 3.162

Review 3.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

4.  Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria.

Authors:  Brian A Stanley; Vidhya Sivakumaran; Sa Shi; Iain McDonald; David Lloyd; Walter H Watson; Miguel A Aon; Nazareno Paolocci
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 5.  Mitochondria in the pathogenesis of diabetes: a proteomic view.

Authors:  Xiulan Chen; Shasha Wei; Fuquan Yang
Journal:  Protein Cell       Date:  2012-06-22       Impact factor: 14.870

Review 6.  Mitochondrial Dynamics and Heart Failure.

Authors:  A A Knowlton; T T Liu
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

Review 7.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

8.  The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.

Authors:  Fariba Raygan; Zohreh Rezavandi; Sahar Dadkhah Tehrani; Alireza Farrokhian; Zatollah Asemi
Journal:  Eur J Nutr       Date:  2015-09-18       Impact factor: 5.614

9.  An orally available hypoglycaemic peptide taken up by caveolae transcytosis displays improved hypoglycaemic effects and body weight control in db/db mice.

Authors:  Weisheng Lu; Hong Tian; Peng Qian; Ying Li; Yongkang Wang; Yang Ge; Wenbo Sai; Xiangdong Gao; Wenbing Yao
Journal:  Br J Pharmacol       Date:  2020-06-07       Impact factor: 8.739

Review 10.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.